Llwytho...
Hyperphosphatemia Management in Patients with Chronic Kidney Disease
Hyperphosphatemia in chronic kidney disease (CKD) patients is a potentially life altering condition that can lead to cardiovascular calcification, metabolic bone disease (renal osteodystrophy) and the development of secondary hyperparathyroidism (SHPT). It is also associated with increased prevalenc...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Saudi Pharm J |
|---|---|
| Prif Awduron: | , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Elsevier
2016
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4908098/ https://ncbi.nlm.nih.gov/pubmed/27330380 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jsps.2015.01.009 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|